




Instance: composition-en-ae95ec75d9c7638e000a13f3c8891532
InstanceOf: CompositionUvEpi
Title: "Composition for mulpleo Package Leaflet"
Description:  "Composition for mulpleo Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp97eac845e5684ebffe036667e902b969)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - mulpleo"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet</p>
<ol>
<li>What Mulpleo is and what it is used for  </li>
<li>What you need to know before you take Mulpleo </li>
<li>How to take Mulpleo  </li>
<li>Possible side effects  </li>
<li>How to store Mulpleo </li>
<li>Contents of the pack and other information </li>
</ol>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What mulpleo is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What mulpleo is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Mulpleo contains the active substance lusutrombopag, which belongs to a group of medicines called 
thrombopoietin receptor agonists. The medicine helps to increase the number of platelets in your 
blood. Platelets are blood components that help the blood to clot and so prevent bleeding. </p>
<p>Mulpleo is used to reduce the risk of bleeding during surgery and other procedures (including 
tooth extractions and endoscopy). It is given to adults who have low numbers of platelets because of 
chronic liver disease. </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take mulpleo"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take mulpleo"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Do not take Mulpleo:</p>
<ul>
<li>if you are allergic to lusutrombopag or any of the other ingredients of this medicine (listed in 
section 6 under  What Mulpleo contains ).<br />
  Check with your doctor if this applies to you before you take Mulpleo </li>
</ul>
<p>Warnings and precautions 
Talk to your doctor:</p>
<ul>
<li>if you are at risk of blood clots in your veins or arteries, or if you previously have had blood 
clots </li>
<li>if you have severe liver disease </li>
<li>if your spleen has been removed </li>
<li>if you are having interferon treatment. 
  Talk to your doctor before taking Mulpleo, if any of these applies. </li>
</ul>
<p>Signs of a blood clot: look out for any of the signs below: </p>
<p>swelling, pain, heat, redness, or tenderness in your leg </p>
<p>sudden shortness of breath, especially with sharp pain in the chest or rapid breathing </p>
<p>pain in the abdomen (tummy), swollen abdomen, blood in your stools.  </p>
<p>Get medical help immediately if you notice any of these. 
Children and adolescents 
Do not give this medicine to children or adolescents under the age of 18 years, because the medicine 
has not been studied in children and adolescents. </p>
<p>Other medicines and Mulpleo 
Tell your doctor if you are taking, have recently taken or might take any other medicines. </p>
<p>Pregnancy and breast-feeding<br />
Do not take Mulpleo if you are pregnant unless your doctor specifically recommends it. The effect of 
Mulpleo during pregnancy is not known. 
- Tell your doctor if you are pregnant, think you may be pregnant, or are planning to have 
a baby. 
- Use reliable methods of contraception while you are taking Mulpleo. 
- If you do become pregnant during treatment with Mulpleo, tell your doctor 
immediately. </p>
<p>Do not breast-feed during treatment with Mulpleo, as it is not known if the medicine passes into 
milk.<br />
  If you are already breast-feeding, talk to your doctor immediately. </p>
<p>Driving and using machines 
Mulpleo has no known effects on your ability to drive or to use machines. </p>
<p>Mulpleo contains sodium 
This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially  sodium-
free . </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take mulpleo"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take mulpleo"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor 
or pharmacist if you are not sure. </p>
<p>Recommended dose: take one tablet once a day, at the same time each day, for seven days only. Take 
the tablet with a liquid and swallow it whole. Do not chew, break, or crush the tablet. You can take it 
with food or between meals.  </p>
<p>Your treatment will start at least 8 days before your surgery or procedure. Do not change the dose or 
schedule for taking Mulpleo unless your doctor or pharmacist tells you to. </p>
<p>If you have severe liver disease, tell your doctor before taking Mulpleo. </p>
<p>If you take more than you should 
If you have taken more Mulpleo than you should, talk to your doctor or go to the hospital. If possible, 
show them the pack, or this leaflet. You may be monitored for side effects associated with excessive 
platelets such as blood clots (see section 2,  Warnings and precautions , and section 4,  Possible side 
effects ). </p>
<p>If you forget to take a tablet 
If you miss a tablet of Mulpleo, take it as soon as you remember on the same day. 
Do not take a double dose to make up for a forgotten tablet. </p>
<p>If you stop taking Mulpleo 
Do not stop taking Mulpleo without talking to your doctor and do not take Mulpleo for more than 
7 days. </p>
<p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. </p>
<p>Higher risk of blood clots<br />
Certain people may have a higher risk of blood clots, including people with liver disease, and 
medicines like Mulpleo could make this problem worse.  </p>
<p>Signs of a blood clot: look out for any of the signs below: </p>
<p>swelling, pain, heat, redness, or tenderness in your leg  </p>
<p>sudden shortness of breath, especially with sharp pain in the chest or rapid breathing  </p>
<p>pain in the abdomen (tummy), swollen abdomen, blood in your stools.<br />
  Get medical help immediately if you notice any of these. </p>
<p>Common side effects<br />
(may affect up to 1 in 10 people) </p>
<p>Headache </p>
<p>Nausea </p>
<p>Blood clot in the liver (portal vein thrombosis) </p>
<p>Rash. </p>
<p>Reporting of side effects 
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side 
effects not listed in this leaflet. You can also report side effects directly via the national reporting 
system listed in Appendix V. </p>
<p>By reporting side effects you can help provide more information on the safety of this medicine. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store mulpleo"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store mulpleo"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this medicine out of the sight and reach of children. </p>
<p>Do not use this medicine after the expiry date which is stated on the carton and blisters after EXP. The 
expiry date refers to the last day of that month. </p>
<p>Store in the original package in order to protect from moisture. </p>
<p>This medicine does not require any special temperature storage conditions. </p>
<p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to 
throw away medicines you no longer use. These measures will help protect the environment. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What Mulpleo contains<br />
- The active substance is lusutrombopag. Each film-coated tablet contains 3 mg lusutrombopag. 
- The other ingredients are:</p>
<ul>
<li>Tablet core: mannitol, microcrystalline cellulose, magnesium oxide, sodium lauryl sulfate, 
hydroxypropylcellulose, carmellose calcium and magnesium stearate (see section 2  Mulpleo 
contains sodium ). </li>
<li>Film coating: hypromellose, titanium dioxide, triethyl citrate, talc and red-ferric oxide (E172) </li>
</ul>
<p>What Mulpleo looks like and contents of the pack </p>
<p>Mulpleo 3 mg film-coated tablets are light red, 7 mm, round, film-coated tablets debossed with the 
Shionogi trademark above the identifier code  551  on one side and debossed with the strength  3  on 
the other side. </p>
<p>Mulpleo is supplied in aluminium blisters in a carton containing 7 film-coated tablets. </p>
<p>Marketing Authorisation Holder<br />
Shionogi B.V. 
Herengracht 1017CA 
Amsterdam 
The Netherlands </p>
<p>Manufacturer<br />
Shionogi B.V. 
Herengracht 1017CA 
Amsterdam 
The Netherlands </p>
<p>For any information about this medicine, please contact the local representative of the Marketing 
Authorisation Holder: </p>
<p>AT, BE, BG, CY, CZ, DK, EE, IE, EL, FI, HR, HU, IE, IS, LT, LU, 
LV, MT, NL, NO, PL, PT, RO, SE, SI, SK<br />
Shionogi B.V. Tel/Tel./Te ./Tlf/T l/Puh/S mi/ :<br />
+31204917contact@shionogi.eu </p>
<p>DE 
Shionogi GmbH 
Tel: +49 (0) 30 2062980 kontakt@shionogi.eu </p>
<p>ES 
Shionogi SLU 
Tel: +34 911 239 contacta@shionogi.eu </p>
<p>IT 
Shionogi Srl 
Tel: +39 06 94 805 contattaci@shionogi.eu </p>
<p>FR 
Shionogi SAS<br />
Tel: +33 (0)1 86 65 58 contactfrance@shionogi.eu </p>
<p>UK (NI)<br />
Shionogi B.V. 
Tel: +44 (0) 28 9124 8contact@shionogi.eu </p>
<p>This leaflet was last revised in<br />
Other sources of information </p>
<p>Detailed information on this medicine is available on the European Medicines Agency web site: </p>         </div>"""      



Instance: composition-da-ae95ec75d9c7638e000a13f3c8891532
InstanceOf: CompositionUvEpi
Title: "Composition for mulpleo Package Leaflet"
Description:  "Composition for mulpleo Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp97eac845e5684ebffe036667e902b969)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - mulpleo"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #da
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Oversigt over indlægssedlen </p>
<ol>
<li>Virkning og anvendelse  </li>
<li>Det skal du vide, før du begynder at tage Mulpleo  </li>
<li>Sådan skal du tage Mulpleo  </li>
<li>Bivirkninger  </li>
<li>Opbevaring  </li>
<li>Pakningsstørrelser og yderligere oplysninger </li>
</ol>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What mulpleo is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What mulpleo is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Mulpleo indeholder det aktive stof lusutrombopag, som tilhører en gruppe af lægemidler, der kaldes 
trombopoietin-receptoragonister. Lægemidlet hjælper med at øge antallet af blodplader i blodet. 
Blodplader er blodkomponenter, der hjælper blodet med at størkne og derved forhindre blødning. </p>
<p>Mulpleo anvendes til at reducere risikoen for blødning under en operation og ved andre indgreb 
(herunder tandudtrækninger og endoskopi). Det gives til voksne, der har et lavt antal blodplader som 
følge af kronisk leversygdom. </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take mulpleo"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take mulpleo"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Tag ikke Mulpleo:</p>
<ul>
<li>hvis du er allergisk over for lusutrombopag eller et af de øvrige indholdsstoffer i Mulpleo 
(angivet i punkt 6 under ‘Mulpleo indeholder’).<br />
➤ Du skal drøfte det med din læge, hvis dette gælder for dig, før du tager Mulpleo </li>
</ul>
<p>Advarsler og forsigtighedsregler<br />
Kontakt lægen:</p>
<ul>
<li>hvis du har risiko for blodpropper i vener eller arterier, eller hvis du tidligere har haft 
blodpropper </li>
<li>hvis du har en svær leversygdom </li>
<li>hvis du har fået fjernet milten </li>
<li>hvis du får behandling med interferon. 
➤ Kontakt lægen, før du tager Mulpleo, hvis noget af dette gælder for dig. </li>
</ul>
<p>Tegn på en blodprop: vær opmærksom på følgende tegn: 
 
hævelse, smerter, varme, rødme eller ømhed i benet 
 
pludselig stakåndethed, især med en borende smerte i brystet eller hurtig vejrtrækning 
 
smerter i maven, opspilet mave, blod i afføringen.  </p>
<p>➤ Søg øjeblikkelig lægehjælp, hvis du bemærker en eller flere af disse ting. </p>
<p>Børn og unge 
Dette lægemiddel må ikke gives til børn eller unge under 18 år, da lægemidlet ikke er blevet undersøgt 
hos børn og unge. </p>
<p>Brug af anden medicin sammen med Mulpleo 
Fortæl det altid til lægen, hvis du tager anden medicin eller har gjort det for nylig. </p>
<p>Graviditet og amning<br />
Tag ikke Mulpleo, hvis du er gravid, medmindre lægen specifikt anbefaler det. Mulpleos virkning 
under graviditeten er ukendt. 
- Tal med lægen, hvis du er gravid, har mistanke om, at du er gravid, eller planlægger at 
blive gravid. 
- Anvend sikre præventionsmetoder, mens du tager Mulpleo. 
- Hvis du bliver gravid i løbet af behandlingen med Mulpleo, skal du straks fortælle det til 
lægen. </p>
<p>Du må ikke amme under behandlingen med Mulpleo, da det er ukendt, om lægemidlet udskilles i 
mælken.<br />
→ Hvis du allerede ammer, skal du straks kontakte din læge. </p>
<p>Trafik- og arbejdssikkerhed 
Mulpleo har ingen kendt virkning på evnen til at føre motorkøretøj eller betjene maskiner. </p>
<p>Mulpleo indeholder natrium 
Dette lægemiddel indeholder mindre end 1 mmol (23 mg) natrium pr. tablet, dvs. det er i det 
væsentlige natrium-frit. </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take mulpleo"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take mulpleo"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Tag altid lægemidlet nøjagtigt efter lægens eller apotekspersonalets anvisning. Er du i tvivl, så spørg 
lægen eller apotekspersonalet. </p>
<p>Anbefalet dosis: tag en tablet en gang dagligt på samme tidspunkt hver dag i kun 7 dage. Tag 
tabletten sammen med væske, og slug den hel. Du må ikke tygge, dele eller knuse tabletten. Du kan 
tage den sammen med mad eller mellem måltiderne.  </p>
<p>Din behandling vil starte mindst 8 dage før din operation eller indgrebet. Du må ikke ændre dosis af 
eller tidsplanen for indtagelsen af Mulpleo, medmindre lægen eller apotekspersonalet fortæller dig det. </p>
<p>Hvis du har en svær leversygdom, skal du fortælle det til lægen, før du tager Mulpleo. </p>
<p>Hvis du har taget for meget 
Hvis du har taget for meget Mulpleo, skal du kontakte lægen eller tage på hospitalet. Hvis det er 
muligt, skal du vise dem pakningen eller denne indlægsseddel. Du kan blive overvåget for 
bivirkninger, der er forbundet med et kraftigt forøget blodpladeantal, såsom blodpropper (se punkt 2, 
‘Advarsler og forsigtighedsregler’ og punkt 4, ’Bivirkninger’). </p>
<p>Hvis du har glemt at tage en tablet 
Hvis du har glemt en tablet med Mulpleo, skal du tage den, så snart du husker det, på den samme dag. 
Du må ikke tage en dobbeltdosis som erstatning for den glemte tablet. </p>
<p>Hvis du holder op med at tage Mulpleo 
Du må ikke holde op med at tage Mulpleo uden at kontakte lægen, og du må ikke tage Mulpleo i mere 
end 7 dage. </p>
<p>Spørg lægen eller apotekspersonalet, hvis der er noget, du er i tvivl om. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Dette lægemiddel kan som al anden medicin give bivirkninger, men ikke alle får bivirkninger. </p>
<p>Større risiko for blodpropper<br />
Visse personer kan have en større risiko for blodpropper, herunder personer med leversygdom, og 
lægemidler som Mulpleo kan forværre dette problem.  </p>
<p>Tegn på en blodprop: vær opmærksom på følgende tegn: 
 
hævelse, smerter, varme, rødme eller ømhed i benet.<br />
 
pludselig stakåndethed, især med en borende smerte i brystet eller hurtig vejrtrækning.<br />
 
smerter i maven, opspilet mave, blod i afføringen.<br />
➤ Søg øjeblikkelig lægehjælp, hvis du bemærker en eller flere af disse ting. </p>
<p>Almindelige bivirkninger<br />
(kan forekomme hos op til 1 ud af 10 personer) 
 
Hovedpine 
 
Kvalme 
 
Blodprop i leveren (portvenetrombose) 
 
Udslæt. </p>
<p>Indberetning af bivirkninger 
Hvis du oplever bivirkninger, bør du tale med din læge, sygeplejerske eller apoteket. Dette gælder 
også mulige bivirkninger, som ikke er medtaget i denne indlægsseddel. Du eller dine pårørende kan 
også indberette bivirkninger direkte til Lægemiddelstyrelsen via det nationale rapporteringssystem 
anført i Appendiks V. </p>
<p>Ved at indrapportere bivirkninger kan du hjælpe med at fremskaffe mere information om sikkerheden 
af dette lægemiddel. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store mulpleo"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store mulpleo"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Opbevar lægemidlet utilgængeligt for børn. </p>
<p>Brug ikke lægemidlet efter den udløbsdato, der står på kartonen og blisterne efter Exp. Udløbsdatoen 
er den sidste dag i den nævnte måned. </p>
<p>Opbevares i den originale yderpakning for at beskytte mod fugt. </p>
<p>Der er ingen særlige krav vedrørende opbevaringstemperaturer for dette lægemiddel. </p>
<p>Spørg på apoteket, hvordan du skal bortskaffe medicinrester. Af hensyn til miljøet må du ikke smide 
medicinrester i afløbet, toilettet eller skraldespanden.  </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Mulpleo indeholder:</p>
<ul>
<li>Aktivt stof: lusutrombopag. Hver filmovertrukket tablet indeholder 3 mg lusutrombopag. </li>
<li>
<p>Øvrige indholdsstoffer:</p>
</li>
<li>
<p>Tabletkerne: mannitol, mikrokrystallinsk cellulose, magnesiumoxid, natriumlaurilsulfat, 
hydroxypropylcellulose, carmellosecalcium og magnesiumstearat (se punkt 2 "Mulpleo 
indeholder natrium"). </p>
</li>
<li>Filmovertræk: hypromellose, titandioxid, triethylcitrat, talcum og rød jernoxid (E172) </li>
</ul>
<p>Udseende og pakningsstørrelser </p>
<p>Mulpleo 3 mg filmovertrukne tabletter er lyserøde, 7 mm runde filmovertrukne tabletter præget med 
Shionogi-varemærket over identifikatorkoden "551" på den ene side og præget med styrken "3" på 
den anden side. </p>
<p>Mulpleo leveres i aluminiumblisters i en æske indeholdende 7 filmovertrukne tabletter. </p>
<p>Indehaver af markedsføringstilladelsen<br />
Shionogi B.V.<br />
Herengracht 1017CA 
Amsterdam 
Holland </p>
<p>Fremstiller<br />
Shionogi B.V.<br />
Herengracht 1017CA 
Amsterdam 
Holland </p>
<p>Hvis du ønsker yderligere oplysninger om dette lægemiddel, skal du henvende dig til den lokale 
repræsentant for indehaveren af markedsføringstilladelsen: </p>
<p>AT, BE, BG, CY, CZ, DK, EE, IE, EL, FI, HR, HU, IE, IS, LT, LU, 
LV, MT, NL, NO, PL, PT, RO, SE, SI, SK<br />
Shionogi B.V. Tel/Tel./Teл./Tlf/Tél/Puh/Sími/Τηλ:<br />
+31204917contact@shionogi.eu </p>
<p>DE 
Shionogi GmbH 
Tel: +49 (0) 30 2062980 kontakt@shionogi.eu </p>
<p>ES 
Shionogi SLU 
Tel: +34 911 239 contacta@shionogi.eu </p>
<p>IT 
Shionogi Srl 
Tel: +39 06 94 805 contattaci@shionogi.eu </p>
<p>FR 
Shionogi SAS<br />
Tel: +33 (0)1 86 65 58 contactfrance@shionogi.eu </p>
<p>UK (NI)<br />
Shionogi B.V. 
Tel: +44 (0) 28 9124 8contact@shionogi.eu </p>
<p>Denne indlægsseddel blev senest ændret  </p>
<p>Andre informationskilder </p>
<p>Du kan finde yderligere oplysninger om dette lægemiddel på Det Europæiske Lægemiddelagenturs 
hjemmeside: http://www.ema.europa.eu.  </p>         </div>"""      





                    
Instance: bundlepackageleaflet-en-ae95ec75d9c7638e000a13f3c8891532
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for mulpleo Package Leaflet for language en"
Description: "ePI document Bundle for mulpleo Package Leaflet for language en"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #en

// Composition
* entry[0].fullUrl = "Composition/composition-en-ae95ec75d9c7638e000a13f3c8891532"
* entry[0].resource = composition-en-ae95ec75d9c7638e000a13f3c8891532

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mpae95ec75d9c7638e000a13f3c8891532"
* entry[=].resource = mpae95ec75d9c7638e000a13f3c8891532
                            
                    
Instance: bundlepackageleaflet-da-ae95ec75d9c7638e000a13f3c8891532
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for mulpleo Package Leaflet for language da"
Description: "ePI document Bundle for mulpleo Package Leaflet for language da"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #da

// Composition
* entry[0].fullUrl = "Composition/composition-da-ae95ec75d9c7638e000a13f3c8891532"
* entry[0].resource = composition-da-ae95ec75d9c7638e000a13f3c8891532

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mpae95ec75d9c7638e000a13f3c8891532"
* entry[=].resource = mpae95ec75d9c7638e000a13f3c8891532
                            
                    



Instance: mpae95ec75d9c7638e000a13f3c8891532
InstanceOf: MedicinalProductDefinitionUvEpi
Title: "Medicinal Product Mulpleo 3 mg film-coated tablets"
Description: "Mulpleo 3 mg film-coated tablets"
Usage: #inline

 
* identifier[+].system = "http://ema.europa.eu/identifier"
* identifier[=].value = "EU/1/18/1348"
* type = http://hl7.org/fhir/medicinal-product-type#MedicinalProduct "Medicinal Product"

* domain = http://hl7.org/fhir/medicinal-product-domain#Human "Human use"

* status = http://hl7.org/fhir/publication-status#active "active"



* legalStatusOfSupply = $spor-rms#100000072084 "Medicinal product subject to medical prescription"

* name
  * productName = "Mulpleo 3 mg film-coated tablets"
  * type = $spor-productNamePartType-cs#220000000001 "Full name" 
  
  * part[0]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000002 "Invented name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000003 "Scientific name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000004 "Strength part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000005 "Pharmaceutical dose form part"
  
  * usage
    * country = urn:iso:std:iso:3166#EU "EU"
    * jurisdiction = urn:iso:std:iso:3166#EU "EU"
    * language = urn:ietf:bcp:47#en  "en"



RuleSet: ae95ec75d9c7638e000a13f3c8891532ListRuleset

* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* identifier[+].system = "http://spor.ema.europa.eu/v2/medicine-name"
* identifier[=].value = "mulpleo"

* status = #current
* mode = #working

* title = "List of all ePIs associated with mulpleo"

* subject = Reference(mp97eac845e5684ebffe036667e902b969)
* subject.extension[0].url = "http://ema.europa.eu/fhir/extension/medicine-name"
* subject.extension[=].valueCoding = $100000000005#mulpleo "mulpleo"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/marketing-authorization-holder"
* subject.extension[=].valueCoding = $100000000005#mah-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/active-substance"
* subject.extension[=].valueCoding = $100000000005#acive-substance-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/domain"
* subject.extension[=].valueCoding = $100000000004#100000000012 "H"

* date = "2015-02-07T13:28:17Z"


* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-en-ae95ec75d9c7638e000a13f3c8891532) // mulpleo en
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "en"



* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-da-ae95ec75d9c7638e000a13f3c8891532) // mulpleo da
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "da"




Instance: List-ae95ec75d9c7638e000a13f3c8891532
InstanceOf: List

* insert ae95ec75d9c7638e000a13f3c8891532ListRuleset
    